![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GlaxoSmithKline Stops RSV Clinical Trials in Pregnant Women
GlaxoSmithKline Stops RSV Clinical Trials in Pregnant Women
GlaxoSmithKline (GSK) said it has stopped enrollment in three phase 3 trials evaluating its respiratory syncytial virus vaccine (RSV) in pregnant women pending further analysis of safety data.
The British drugmaker paused the trials last week, following a recommendation from the independent data monitoring committee after a routine safety assessment. However, GSK has not said what those safety findings were.
GSK said it will continue a phase 3 clinical trial for RSV in adults who are 60 years and up. Results from that trial are expected during the first half of this year.
Upcoming Events
-
21Oct